These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37230954)

  • 1. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study.
    Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ;
    Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD-MBD biomarkers and CKD progression: an analysis by the joint model.
    D'Arrigo G; Mallamaci F; Pizzini P; Leonardis D; Tripepi G; Zoccali C
    Nephrol Dial Transplant; 2023 Mar; 38(4):932-938. PubMed ID: 35790138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS.
    Nitta K; Bieber B; Karaboyas A; Johnson DW; Kanjanabuch T; Kim YL; Lambie M; Hartman J; Shen JI; Naljayan M; Pecoits-Filho R; Robinson BM; Pisoni RL; Perl J; Kawanishi H
    Perit Dial Int; 2024 Jul; 44(4):275-286. PubMed ID: 38501163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.
    Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M
    Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
    Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
    J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
    Hu L; Napoletano A; Provenzano M; Garofalo C; Bini C; Comai G; La Manna G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
    Pazianas M; Miller PD
    J Bone Miner Res; 2020 Dec; 35(12):2313-2317. PubMed ID: 32780482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.
    Yamada S; Nakano T
    J Atheroscler Thromb; 2023 Aug; 30(8):835-850. PubMed ID: 37258233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
    Hsu CY; Chen LR; Chen KH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
    Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D
    Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
    Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
    Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
    Rroji M; Figurek A; Spasovski G
    Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32106499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study.
    Wakasugi M; Narita I
    J Bone Miner Metab; 2022 Sep; 40(5):810-818. PubMed ID: 35759144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis.
    Martín-Carro B; Navarro-González JF; Ortiz A; Zoccali C; Floege J; Ferreira MA; Gorriz-Teruel JL; Carrillo-López N; Panizo S; Locatelli F; Ketteler M; London GM; Naves-Díaz M; Alonso-Montes C; Cannata-Andía JB; Fernández-Martín JL
    Nephrol Dial Transplant; 2023 Oct; 38(11):2589-2597. PubMed ID: 37349949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.
    Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; de Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L
    BMC Nephrol; 2019 Jul; 20(1):258. PubMed ID: 31299919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.